1 - 10 out of 14Page size: 10
  1. 2022

  2. Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile

    Sharonova, T., Zhmurov, P., Kalinin, S., Nocentini, A., Angeli, A., Ferraroni, M., Korsakov, M., Supuran, C. T. & Krasavin, M., 16 Mar 2022, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 37, 1, p. 857-865 9 p.

    Research output: Contribution to journal › Article › peer-review

  3. (E)-3-Arylidene-4-diazopyrrolidine-2,5-diones conveniently elaborated into cytotoxic compounds bearing primary sulfonamide and Michael acceptor moieties

    Paramonova, P., Sharonova, T., Kalinin, S., Chupakhin, E., Bunev, A. & Krasavin, M., 1 Mar 2022, In: Mendeleev Communications . 32, 2, p. 176-177 2 p.

    Research output: Contribution to journal › Article › peer-review

  4. Synthesis, Structure, and Antiproliferative Action of 2-Pyridyl Urea-Based Cu(II) Complexes

    Geyl, K. K., Baykov, S. V., Kalinin, S. A., Bunev, A. S., Troshina, M. A., Sharonova, T. V., Skripkin, M. Y., Kasatkina, S. O., Presnukhina, S. I., Shetnev, A. A., Krasavin, M. Y. & Boyarskiy, V. P., 16 Feb 2022, In: Biomedicines. 10, 2, 18 p., 461.

    Research output: Contribution to journal › Article › peer-review

  5. 2021

  6. Carbonic anhydrase IX inhibitors as candidates for combination therapy of solid tumors

    Kalinin, S., Malkova, A., Sharonova, T., Sharoyko, V., Bunev, A., Supuran, C. T. & Krasavin, M., 14 Dec 2021, In: International Journal of Molecular Sciences. 22, 24, 13405.

    Research output: Contribution to journal › Review article › peer-review

  7. Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589))

    Dar'in, D., Kantin, G., Kalinin, S., Sharonova, T., Bunev, A., Ostapenko, G. I., Nocentini, A., Sharoyko, V., Supuran, C. T. & Krasavin, M., 1 Dec 2021, In: European Journal of Medicinal Chemistry. 225, 1 p., 113788.

    Research output: Contribution to journal › Comment/debate › peer-review

  8. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent

    Dar'in, D., Kantin, G., Kalinin, S., Sharonova, T., Bunev, A., Ostapenko, G. I., Nocentini, A., Sharoyko, V., Supuran, C. T. & Krasavin, M., 15 Oct 2021, In: European Journal of Medicinal Chemistry. 222, 14 p., 113589.

    Research output: Contribution to journal › Article › peer-review

  9. Insertion of metal carbenes into the anilinic N–H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms

    Sharonova, T., Paramonova, P., Kalinin, S., Bunev, A., Gasanov, R., Nocentini, A., Sharoyko, V., Tennikova, T. B., Dar'in, D., Supuran, C. T. & Krasavin, M., 1 Jun 2021, In: European Journal of Medicinal Chemistry. 218, 15 p., 113352.

    Research output: Contribution to journal › Article › peer-review

  10. INSERTION OF Rh(II)-CARBENES INTO THE ANILINIC N-H BOND OF UNPROTECTED AMINOBENZENESULFONAMIDES IN THE SYNTHESIS OF NOVEL HUMAN CARBONIC ANHYDRASE AND HUMAN TIOREDOXIN REDUCTASE INHIBITORS

    Парамонова, П. С., Красавин, М. Ю., Шаронова, Т. В. & Калинин, С. А., 2021.

    Research output: Contribution to conference › Abstract › peer-review

  11. КОМБИНИРОВАНИЕ ФАРМАКОФОРНЫХ ФРАГМЕНТОВ, ИНГИБИРУЮЩИХ КАРБОАНГИДРАЗУ И ТИОРЕДОКСИНРЕДУКТАЗУ, В ОДНОЙ МОЛЕКУЛЕ – НОВЫЙ ПОДХОД К УВЕЛИЧЕНИЮ ЦИТОТОКСИЧНОСТИ ПРИ РАЗРАБОТКЕ ПРОТИВОРАКОВЫХ ПРЕПАРАТОВ

    Шаронова, Т. В., 2021, p. 596-599. 4 p.

    Research output: Contribution to conference › Paper

  12. НОВЫЙ ПОДХОД К РАЗРАБОТКЕ ПРОТИВОРАКОВЫХ ПРЕПАРАТОВ, ОСНОВАННЫЙ НА ОБЪЕДИНЕНИИ ДВУХ ФАРМАКОФОРНЫХ ФРАГМЕНТОВ, ИНГИБИРУЮЩИХ КАРБОАНГИДРАЗУ И ТИОРЕДОКСИНРЕДУКТАЗУ, В ОДНОЙ МОЛЕКУЛЕ

    Шаронова, Т. В., 2021, p. 388-390. 3 p.

    Research output: Contribution to conference › Paper

Previous 1 2 Next

ID: 32562152